You are viewing an incomplete version of our website. Please click to reload the website as full version.

Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2) (C-Term) antibody

Details for Product No. ABIN358989, Supplier: Log in to see
Antigen
  • CG10523
  • Dmel\\CG10523
  • Dpark
  • SD01679
  • dpk
  • si:ch211-123f21.1
  • zgc:112390
  • LOC100150461
  • PRKN
  • Park
  • Prkn
  • AR-JP
  • LPRS2
  • PDJ
  • pdr-1
Epitope
C-Term
26
24
24
17
5
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
Reactivity
Human
184
47
39
10
6
3
3
2
2
1
1
Host
Rabbit
163
16
11
Clonality
Polyclonal
Conjugate
Un-conjugated
5
4
4
3
3
3
3
3
3
3
3
3
Application
Enzyme Immunoassay (EIA), Western Blotting (WB)
141
63
54
33
30
25
12
11
5
2
1
1
1
1
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Available images

Immunogen This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide in the C-terminal region of human Park2.
Isotype Ig
Specificity This antibody reacts to PARK2 (Parkin).
Purification Prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS
Alternative Name PARK2 / Parkin (PARK2 Antibody Abstract)
Background Parkinson is the second most common neurodegenerative disease after Alzheimers. About 1 percent of people over the age of 65 and 3 percent of people over the age of 75 are affected by the disease. The mutation is the most common cause of Parkinson disease identified to date. The function of Park2 is not well-known, however, it may play a role in the ubiquitin-mediated proteolytic pathway. Mutations in this gene are known to cause autosomal recessive juvenile parkinsonism. Alternative splicing of this gene produces three known products of undetermined function.Synonyms: AR-JP, E3 ubiquitin-protein ligase parkin, LPRS2, PDJ, PRKN, Parkinson disease 2, Parkinson juvenile disease protein 2
Gene ID 5071
NCBI Accession NP_004553
UniProt O60260
Application Notes ELISA: 1/1,000. Western blotting: 1/100 - 1/500.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions For Research Use only
Format Liquid
Concentration 0.25 mg/mL
Buffer PBS with 0.09 % (W/V) sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice Avoid repeated freezing and thawing.
Storage 4 °C/-20 °C
Storage Comment Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.
Supplier Images
Western Blotting (WB) image for anti-Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2) (C-Term) antibody (ABIN358989) Western blot analysis of anti-PARK2 (Parkin) Antibody (N-term) in NCI-H460 cell line ...
Background publications Kumru, Santamaria, Tolosa et al.: "Rapid eye movement sleep behavior disorder in parkinsonism with parkin mutations." in: Annals of neurology, Vol. 56, Issue 4, pp. 599-603, 2004 (PubMed).

Pigullo, De Luca, Barone et al.: "Mutational analysis of parkin gene by denaturing high-performance liquid chromatography (DHPLC) in essential tremor." in: Parkinsonism & related disorders, Vol. 10, Issue 6, pp. 357-62, 2004 (PubMed).